NSE: MAXHEALTH · 13 October 2026
- Max Healthcare Institute Limited shares declined 2.81% on Monday, trading within a day's range of ₹842.30 and ₹860.10 after opening at ₹853.25.
- Max Healthcare announced that CARE Ratings Limited upgraded the credit ratings for its wholly-owned material subsidiary Crosslay Remedies Limited, formerly known as Jaypee Healthcare Limited. Long-term bank facilities were revised to CARE AA+; Stable, while short-term bank facilities were reaffirmed at CARE A1+. The company received the formal communication on October 9, 2026.
- Trading volume was 0.24 times the 20-day average daily volume.
Why is Max Healthcare Ins share price falling on 13 October 2026?
Max Healthcare Institute Limited shares declined 2.81% on Monday, trading within a day's range of ₹842.30 and ₹860.10 after opening at ₹853.25.
The broader market exhibited positive momentum as the Nifty benchmark rose 0.56%, whereas the sector benchmark Nifty Pharma dipped 0.26%. Max Healthcare's decline of 2.81% reflects relative weakness compared to both the broader market and its immediate sector index. Over a broader horizon, the stock has experienced recent downward pressure, registering a 5-day return of -6.32% and a 20-day return of -17.29%.
Company disclosures from early October show that CARE Ratings Limited upgraded and reaffirmed credit ratings for subsidiary Crosslay Remedies Limited and the parent company, while ongoing legal proceedings involving Kalinga Hospital Limited remain scheduled for further hearing before the NCLT on October 29, 2026. However, these updates provide general corporate context rather than a proven direct catalyst for today's downward price move.
7.08 lakh shares traded by 13 October 2026 · 09:35 AM IST. This compares with a 20-day average daily volume of 30.03 lakh shares (0.24 times). The five-day average daily volume was 30.31 lakh shares. Separately, the NSE report for 12 October 2026 showed 11.94 lakh shares delivered, representing 58.71% of that day’s traded volume. The same report recorded 76,691 trades.
The stock declined alongside a weak sector backdrop, extending its multi-week correction despite quiet trading volumes and no single confirmed same-day operational catalyst.
Latest Company Developments
Max Healthcare announced that CARE Ratings Limited upgraded the credit ratings for its wholly-owned material subsidiary Crosslay Remedies Limited, formerly known as Jaypee Healthcare Limited. Long-term bank facilities were revised to CARE AA+; Stable, while short-term bank facilities were reaffirmed at CARE A1+. The company received the formal communication on October 9, 2026.
An upgraded credit profile for a key subsidiary strengthens the group's overall financial standing and borrowing terms.
The company reported that CARE Ratings Limited reaffirmed its credit ratings on long-term and short-term bank facilities. Long-term bank facilities aggregating ₹1,818.88 crore received a CARE AA+; Stable rating, and short-term facilities of ₹80.00 crore were reaffirmed at CARE A1+. The intimation follows communication received from the rating agency on October 8, 2026.
Reaffirmation of top-tier credit ratings underscores the company's stable financial position and creditworthiness.
The National Company Law Tribunal Cuttack Bench could not hear petitions filed by legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Limited and Max Healthcare due to paucity of time. The matter has been adjourned to October 29, 2026, for further hearing.
It keeps ongoing legal scrutiny regarding the Kalinga Hospital acquisition pending without an immediate resolution.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 18.68% on 30 June 2026. This compares with 16.30% on 31 March 2026, a change of +2.38 percentage points.
The filing reported 42 MF/UTI holders.
What to Watch Next
- Developments regarding the adjourned NCLT hearing for Kalinga Hospital on October 29, 2026
- Outcome and voting results of the ongoing postal ballot ending October 19, 2026
- Delivery volume trends relative to the 20-day average volume of 0.24x
- Sector performance relative to Nifty Pharma and broader market indices
Other Dated Coverage
- Why MAXHEALTH Shares Fell 1.58% Today: Sector Divergence Explored | 6 October 2026 — 6 October 2026
- Why Max Healthcare Shares Fell 2.55% Today: Sector Weakness & Pullback | 5 October 2026 — 5 October 2026
- Max Healthcare in Focus Today on Litigation Disclosures and Prior Losses | 1 October 2026 — 1 October 2026
More Max Healthcare Ins news and dated analysis →
Frequently Asked Questions
What is the latest Max Healthcare Ins company news?
Max Healthcare announced that CARE Ratings Limited upgraded the credit ratings for its wholly-owned material subsidiary Crosslay Remedies Limited, formerly known as Jaypee Healthcare Limited. Long-term bank facilities were revised to CARE AA+; Stable, while short-term bank facilities were reaffirmed at CARE A1+. The company received the formal communication on October 9, 2026.
How strong was Max Healthcare Ins’s trading volume?
7.08 lakh shares traded, 0.24 times the 20-day average daily volume. The price and volume data are dated 13 October 2026 · 09:35 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.